Finding a cure for sickle cell disease
Cure Sickle Cell
The Cure Sickle Cell Initiative is bringing together patients, families, and caregivers to work together on finding a cure for sickle cell disease using safe genetic therapies, with the goal of improving lives and speeding up the development of new treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Medical College of Wisconsin NIH-funded |
| Lab location | 1 site (Milwaukee, United States) |
| Project ID | NIH-9787629 on NIH RePORTER |
What this research studies
The Cure Sickle Cell Initiative aims to engage the sickle cell disease community, including patients, families, and caregivers, to collaboratively work towards finding a cure. This initiative focuses on utilizing safe and reliable genetic therapies to improve the lives of individuals affected by sickle cell disease. By fostering partnerships between government agencies, biopharmaceutical companies, and researchers, the project seeks to accelerate the development of innovative treatments and technologies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with sickle cell disease, including those with Hb SS disease.
Not a fit: Patients with other types of anemia or those without a diagnosis of sickle cell disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to groundbreaking genetic therapies that significantly improve or even cure sickle cell disease.
How similar studies have performed: Other research initiatives exploring genetic therapies for sickle cell disease have shown promising results, indicating a potential for success in this area.
Where this research is happening
Milwaukee, United States
- Medical College of Wisconsin — Milwaukee, United States (Active)
Researchers
- Principal investigator: Eapen, Mary — Medical College of Wisconsin
- Study coordinator: Eapen, Mary
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.